JPMorgan Chase & Co’s Century Therapeutics IPSC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.47K | Sell |
2,637
-66,853
| -96% | -$37.3K | ﹤0.01% | 5689 |
|
|
2025
Q1 | $33.1K | Sell |
69,490
-93,699
| -57% | -$44.6K | ﹤0.01% | 5149 |
|
|
2024
Q4 | $165K | Buy |
163,189
+91,468
| +128% | +$92.4K | ﹤0.01% | 4607 |
|
|
2024
Q3 | $123K | Buy |
71,721
+51,664
| +258% | +$88.3K | ﹤0.01% | 4648 |
|
|
2024
Q2 | $51.1K | Sell |
20,057
-5,623
| -22% | -$14.3K | ﹤0.01% | 4895 |
|
|
2024
Q1 | $107K | Buy |
25,680
+10,498
| +69% | +$43.9K | ﹤0.01% | 4704 |
|
|
2023
Q4 | $50.4K | Sell |
15,182
-11,341
| -43% | -$37.7K | ﹤0.01% | 5010 |
|
|
2023
Q3 | $53K | Buy |
26,523
+5,807
| +28% | +$11.6K | ﹤0.01% | 4889 |
|
|
2023
Q2 | $65.5K | Sell |
20,716
-45,036
| -68% | -$142K | ﹤0.01% | 4799 |
|
|
2023
Q1 | $228K | Buy |
65,752
+291
| +0.4% | +$1.01K | ﹤0.01% | 4256 |
|
|
2022
Q4 | $335K | Buy |
65,461
+2,360
| +4% | +$12.1K | ﹤0.01% | 3958 |
|
|
2022
Q3 | $624K | Sell |
63,101
-2,255
| -3% | -$22.3K | ﹤0.01% | 3619 |
|
|
2022
Q2 | $548K | Buy |
65,356
+6,237
| +11% | +$52.3K | ﹤0.01% | 3818 |
|
|
2022
Q1 | $744K | Sell |
59,119
-81,834
| -58% | -$1.03M | ﹤0.01% | 3786 |
|
|
2021
Q4 | $2.24M | Buy |
140,953
+77,529
| +122% | +$1.23M | ﹤0.01% | 3160 |
|
|
2021
Q3 | $1.6M | Buy |
+63,424
| New | +$1.6M | ﹤0.01% | 3308 |
|